TOP STORIES

• REGULATORY Chuikyo Talks Over Sales Criteria to Trigger Possible Xocova Re-Pricing; Is 3-Month-Based Estimate an Overestimate?
  February 9, 2023

• BUSINESS CSL Behring Soon to Launch Home Delivery Service for Hemophilia Therapies
  February 8, 2023

• BUSINESS Next Astellas CEO Says Weathering Xtandi Cliff Is His Biggest Mission
  February 7, 2023

• REGULATORY Expert Panel Member Sakamaki Wants Pricing Overhaul to Push Generic Industry Consolidation
  February 6, 2023

• BUSINESS Astellas EVP Okamura to Become CEO in April
  February 6, 2023

• BUSINESS Mitsubishi Chemical Calls It Quit for Medicago, COVID Jab
  February 6, 2023

• BUSINESS Chugai’s Sales Hit 1-Trillion-Yen Mark in 2022 on New Launches, Ronapreve
  February 3, 2023

• REGULATORY Chuikyo OKs Use of Multiple Comparators to Price Xocova, Upping of Reduction Cap Mooted for Re-Pricing
  February 2, 2023

• BUSINESS Daiichi Sankyo Taps CFO Okuzawa as New President, Set to Continue ADC Drive
  February 1, 2023

• BUSINESS Shionogi Logs Record Profits as Xocova Nets 100 Billion Yen from Govt Purchase: April-December
  January 31, 2023

• BUSINESS Lecanemab Earns Priority Review in Japan, Eisai Aims for Approval by Year-End
  January 31, 2023

• REGULATORY Panel OKs Japan’s First Abortion Pill, but Upper Organ to Review It Again after Public Comments
  January 30, 2023

• REGULATORY Experts Doubt Necessity of Policy Intervention for LLP-Dependent Companies
  January 27, 2023

• REGULATORY Chuikyo Begins Xocova Price Debate under Mega Seller Rule, Weighs Quicker Re-Pricing
  January 26, 2023

• ORGANIZATION PhRMA Poised to Issue 2024 Reform Proposal in Next Few Months: New Japan Chief
  January 25, 2023

• REGULATORY Xocova Might Trigger Mega Seller Price Control Rule for First Time
  January 24, 2023

• REGULATORY Setting “Presumed Efficacy” Criteria Would Be Difficult; Xocova Decision Reasonable: PMDA Chief
  January 23, 2023

• BUSINESS Opdivo Outdistances Keytruda in 2022 with Sales Up 30 Billion Yen YOY: Encise
  January 20, 2023

• REGULATORY Former Minister Nemoto to Initiate Debates on Pharma Policies by Young Lawmakers
  January 19, 2023

• BUSINESS Ex-Sandoz Japan Chief Tapped to Spearhead Nichi-Iko Turnaround
  January 18, 2023

ページ

• « 先頭
• ‹ Prev
• …
• 59
• 60
• 61
• 62
• 63
• 64
• 65
• 66
• 67
• …
• Next ›
• 最終 »